Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

High Risk

Score: 75/100

Failure Rate

25.0%

1 terminated/withdrawn out of 4 trials

Success Rate

66.7%

-19.8% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 2 completed trials have results

Key Signals

1 recruiting

Enrollment Performance

Analytics

N/A
2(66.7%)
Phase 2
1(33.3%)
3Total
N/A(2)
Phase 2(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (4)

Showing 4 of 4 trials
NCT06323330Not ApplicableRecruiting

Music Therapy for Rehabilitation in Post-stroke Non-fluent Aphasia: the Indian Adaptation

Role: collaborator

NCT06433804Completed

Clinicopathological Parameters of HER2 Low Breast Cancers

Role: lead

NCT01723501Phase 2Withdrawn

Chlorhexidine Skin Application for Prevention of Infection in Infants Weighing <1500 g at Birth

Role: collaborator

NCT01367015Not ApplicableCompleted

Early Versus Late Initiation of Feeding in Premature Growth Restricted Newborns With Absent or Reversed End Diastolic Flow On Umbilical Artery Doppler (AREDF)

Role: collaborator

All 4 trials loaded